A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS)
Abstract
:1. Introduction: Background and Rationale for Supervision in Psychedelic Therapy
1.1. A Critical Review of Supervision in Psychotherapy
1.2. Proposing a Motivational-Interviewing-Enhanced Integration Supervision Strategy for PAT
2. A Model for Supervision in PAT
2.1. Targeted Behaviors for PAT Supervision
2.2. Using MI to Engage Clients and Trainees in Integration Practices
3. Conclusions and a Clarion Call for Research
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- The Royal Australian and New Zealand College of Psychiatrists. Professional Practice Guideline 4: ‘Off-Label’ Prescribing in Psychiatry. Available online: https://www.ranzcp.org/getmedia/edc66b1d-005b-411d-b277-5c7fddc71ba2/PPG-4-Off-label-prescribing-December-2023.pdf (accessed on 24 April 2025).
- The Royal College of Psychiatrists. Statement on Ketamine to Treat Depression. Available online: https://www.rcpsych.ac.uk/docs/default-source/about-us/who-we-are/ect-committee/ectcommittee-ketamine-to-treat-depression-statement-feb17.pdf?sfvrsn=db4e7a95_6 (accessed on 24 April 2025).
- Alberta Health Services. Intravenous Ketamine for the Treatment of Adult Depression. Available online: https://extranet.ahsnet.ca/teams/policydocuments/1/clp-amh-ahs-iv-ketamine-amh-10-01.pdf (accessed on 24 April 2025).
- United States Food and Drug Administration. FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression; Available Only at a Certified Doctor’s Office or Clinic. Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified (accessed on 24 April 2025).
- Reiff, C.M.; Richman, E.E.; Nemeroff, C.B.; Carpenter, L.L.; Widge, A.S.; Rodriguez, C.I.; Kalin, N.H.; McDonald, W.M.; The Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and psychedelic-assisted psychotherapy. Am. J. Psychiatry 2020, 177, 391–410. [Google Scholar] [CrossRef] [PubMed]
- Brennan, W.; Belser, A.B. Models of psychedelic-assisted psychotherapy: A contemporary assessment and an introduction to EMBARK, a transdiagnostic, trans-drug model. Front. Psychol. 2022, 13, 866018. [Google Scholar] [CrossRef]
- Phelps, J. Developing guidelines and competencies for the training of psychedelic therapists. J. Humanist. Psychol. 2017, 57, 450–487. [Google Scholar] [CrossRef]
- Barber, G.; Nemeroff, C.B.; Siegel, S. A case of prolonged mania, psychosis, and severe depression after psilocybin use: Implications of increased psychedelic drug availability. Am. J. Psychiatry 2022, 179, 892–896. [Google Scholar] [CrossRef]
- Perna, J.; Trop, J.; Palitsky, R.; Bosshardt, Z.; Vantine, H.; Dunlop, B.W.; Zarrabi, A.J. Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: A case report. BMC Psychiatry 2025, 25, 184. [Google Scholar] [CrossRef] [PubMed]
- American Psychological Association. Guidelines for clinical supervision in health service psychology. Am. Psychol. 2014, 70, 33–46. [Google Scholar] [CrossRef]
- National Association of Social Workers. Best Practice Standards in Social Work Supervision. Available online: https://www.aswb.org/regulation/research/supervision-resources (accessed on 10 July 2024).
- Bernard, J.M.; Goodyear, R.K. Fundamentals of Clinical Supervision, 6th ed.; Pearson: New York, NY, USA, 2019. [Google Scholar]
- Rogers, C.R. The necessary and sufficient conditions of therapeutic personality change. J. Consult. Psychol. 1957, 21, 95–103. [Google Scholar] [CrossRef]
- Rogers, C.R. On Becoming a Person: A Therapist’s View of Psychotherapy; Houghton Mifflin: Boston, MA, USA, 1961. [Google Scholar]
- Teichman, Y.; Berant, E.; Shenkman, G.; Ramot, G. Supervisee’s perspectives on the contribution of supervision to psychotherapy outcomes. Couns. Psychother. Res. 2023, 23, 516–529. [Google Scholar] [CrossRef]
- Goldberg, S.B.; Rousmaniere, T.; Miller, S.D.; Whipple, J.; Nielsen, S.L.; Hoyt, W.T.; Wampold, B.E. Do psychotherapists improve with time and experience? A longitudinal analysis of outcomes in a clinical setting. J. Couns. Psychol. 2016, 63, 1–11. [Google Scholar] [CrossRef]
- Ladany, N.; Ellis, M.V.; Friedlander, M.L. The supervisory working alliance, trainee self-efficacy, and satisfaction. J. Couns. Dev. 1999, 77, 447–455. [Google Scholar] [CrossRef]
- Watkins, C.E. Does psychotherapy supervision contribute to patient outcomes? Considering thirty years of research. Clin. Superv. 2011, 30, 235–256. [Google Scholar] [CrossRef]
- Lambert, M.J.; Morton, J.J.; Hatfield, D.; Harmon, C.; Hamilton, S.; Reid, R.C.; Shimokawa, K.; Christopherson, C.; Burlingame, G.M. Administration and Scoring Manual for the Outcome Questionnaire-45; American Professional Credentialing Services LLC: Nashville, TN, USA, 2004. [Google Scholar]
- Rousmaniere, T.G.; Swift, J.K.; Babins-Wagner, R.; Whipple, J.L.; Berzins, S. Supervisor variance in psychotherapy outcome in routine practice. Psychother. Res. 2014, 26, 196–205. [Google Scholar] [CrossRef] [PubMed]
- Whipple, J.; Hoyt, T.; Rousmaniere, T.; Swift, J.; Pedersen, T.; Worthen, V. Supervisor variance in psychotherapy outcome in routine practice: A replication. Sage Open 2020, 10, 2158244019899047. [Google Scholar] [CrossRef]
- Alfonsson, S.; Spännargård, Å.; Parling, T.; Andersson, G.; Lundgren, T. The effects of clinical supervision on supervisees and patients in cognitive-behavioral therapy: A study protocol for a systematic review. Syst. Rev. 2018, 47, 206–228. [Google Scholar] [CrossRef] [PubMed]
- Wheeler, S.; Richards, K. The impact of clinical supervision on counsellors and therapists, their practice, and their clients: A systematic review of the literature. Couns. Psychother. Res. 2007, 7, 54–65. [Google Scholar] [CrossRef]
- Barrett, J.; Gonsalvez, C.J.; Shires, A. Evidence-based practice within supervision during psychology practitioner training: A systematic review. Clin. Psychol. 2020, 24, 3–17. [Google Scholar] [CrossRef]
- Earleywine, M.; Low, F.; Lau, C.; De Leo, J. Integration in psychedelic-assisted treatments: Recurring themes in current providers’ definitions, challenges, and concerns. J. Humanist. Psychol. 2022. [Google Scholar] [CrossRef]
- Falender, C.A.; Shafranske, E.P. Clinical Supervision: A Competency-Based Approach; American Psychological Association: Washington, DC, USA, 2004. [Google Scholar]
- Miller, W.R.; Rollnick, S. Motivational Interviewing: Helping People Change and Grow, 4th ed.; The Guilford Press: New York, NY, USA, 2023. [Google Scholar]
- Teixeira, P.J.; Johnson, M.W.; Timmermann, C.; Watts, R.; Erritzoe, D.; Douglass, H.; Kettner, H.; Carhart-Harris, R.L. Psychedelics and health behaviour change. J. Psychopharmacol. 2022, 36, 12–19. [Google Scholar] [CrossRef]
- Geary, M.R.; Shortway, K.M.; Marks, D.R.; Block-Lerner, J. Psychology doctoral students’ self-care during the COVID-19 pandemic: Relationships among satisfaction with life, stress levels, and self-compassion. Train. Educ. Prof. Psychol. 2023, 17, 323–330. [Google Scholar] [CrossRef]
- Earleywine, M.; Gomez, S.G. Is personal experience essential for effective psychedelic therapists?: The challenges of small, accumulating therapist effects. Psychedelic Med. 2024, 2, 138–145. [Google Scholar] [CrossRef]
- Aday, J.S.; Skiles, Z.; Eaton, N.; Fredenburg, L.; Pleet, M.; Mantia, J.; Bradley, E.; Fernandes-Osterhold, G.; Woolley, J.D. Personal psychedelic use is common among a sample of psychedelic therapists: Implications for research and practice. Psychedelic Med. 2023, 1, 27–37. [Google Scholar] [CrossRef] [PubMed]
- Earleywine, M.; Low, F.; Altman, B.R.; De Leo, J. How important is a guide who has taken psilocybin in psilocybin-assisted therapy for depression? J. Psychoactive Drugs. 2023, 55, 51–61. [Google Scholar] [CrossRef] [PubMed]
- Frymann, T.; Whitney, S.; Yaden, D.B.; Lipson, J. The psychedelic integration scales: Tools for measuring psychedelic integration behaviors and experiences. Front. Psychol. 2022, 13, 863247. [Google Scholar] [CrossRef] [PubMed]
- Mian, M.N.; Altman, B.R.; Earleywine, M. Ayahuasca’s antidepressant effects covary with behavioral activation as well as mindfulness. J. Psychoactive Drugs. 2020, 52, 130–137. [Google Scholar] [CrossRef]
- Yaden, D.B.; Kaufman, S.B.; Hyde, E.; Chirico, A.; Gaggioli, A.; Zhang, J.W.; Keltner, D. The development of the Awe Experience Scale (AWE-S): A multifactorial measure for a complex emotion. J. Posit. Psychol. 2018, 14, 474–488. [Google Scholar] [CrossRef]
- Bell, T.; Hickey, T.; Bennett-Levy, J. Self-Practice/Self-Reflection (SP/SR) Training for Compassion-Focused Therapists. In Compassion Focused Therapy: Clinical Practice and Applications; Gilbert, P., Simos, G., Eds.; Routledge: London, UK, 2022; pp. 371–384. [Google Scholar]
- Hattie, J.; Timperley, H. The power of feedback. Rev. Educ. Res. 2007, 77, 81–112. [Google Scholar] [CrossRef]
- Heffner, C.L.; Cowan, J.A. The Strength-Based Clinical Supervision Workbook: A Complete Guide for Mental Health Trainees and Supervisors; Routledge: London, UK, 2022. [Google Scholar]
Supervisory Feature | Stereotypical Traditional Supervision | Additional Elements in MIE-IS |
---|---|---|
Primary goals | Develop skills, uphold ethical standards, support client welfare [12] | Support meaning-making in integration sessions; promote autonomy and values-congruent growth for the trainee |
Supervisor stance | Supportive expert, evaluator, gatekeeper [26] | Adds collaborative, evocative stance rooted in Motivational Interviewing [27] |
Trainee development | Focuses on competency, protocol adherence, and insight into client dynamics | Builds capacity to navigate ambiguity in integration; supports reflection on trainee’s stance toward nonordinary experiences |
Client representation | Typically case-based, often represented through clinical data and symptom reports | Emphasizes client as co-creator of integration meaning; attends to client autonomy and values within supervision conversations |
Content focus | Case conceptualization, diagnosis, treatment planning, ethical challenges | Adds focus on psychedelic-specific integration challenges (e.g., ontological shock, spiritual insights, ineffability) |
Session process | Supervisor-guided discussions, often structured around competency checklists or case reviews | Includes MI-consistent elements such as open questions, reflective listening, exploring ambivalence about integration themes |
Theory integration | Often draws from evidence-based treatment models for case formulations | Integrates MI theory and spirit (collaboration, evocation, autonomy support) with psychedelic-specific integration needs |
Outcome orientation | Evaluates supervisee’s effectiveness and ethical practice; monitors client outcomes | Adds emphasis on supervisee’s ability to support flexible, personally meaningful integration for clients navigating altered states |
Attention to therapist and supervisor experience | Often implicit or addressed only when problems arise (e.g., burnout, reactivity) | Explicitly incorporates reflection on therapist’s inner experience, meaning-making, and values alignment; invites supervisors to model presence, flexibility, and curiosity |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Earleywine, M.; Oliva, A.B. A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS). Psychoactives 2025, 4, 14. https://doi.org/10.3390/psychoactives4020014
Earleywine M, Oliva AB. A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS). Psychoactives. 2025; 4(2):14. https://doi.org/10.3390/psychoactives4020014
Chicago/Turabian StyleEarleywine, Mitch, and Alyssa B. Oliva. 2025. "A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS)" Psychoactives 4, no. 2: 14. https://doi.org/10.3390/psychoactives4020014
APA StyleEarleywine, M., & Oliva, A. B. (2025). A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS). Psychoactives, 4(2), 14. https://doi.org/10.3390/psychoactives4020014